Wan Shazlin Asmidar Wan Azhar1, Lim Yih Wei1, Seri Narti Edayu Sarchio2, Suhaili Shamsi1*
1. Animal Biochemistry and Biotechnology Lab, Department of Biochemistry, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2. Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
*Corresponding author: Suhaili Shamsi.
ABSTRACT
INTRODUCTION: Wounds are defined as disruptions to normal anatomical structure and function. Wound healing is a complex biological process influenced by oxidative stress, inflammation, and cytokine activity. Current treatments are costly, inefficient, and often result in scarring. Curcumin (CUR), a bioactive phenolic compound isolated from turmeric, exhibits potent wound healing properties through its anti-inflammatory, antioxidant, and antimicrobial activities. It promotes collagen synthesis, enhances fibroblast proliferation, and accelerates re-epithelialisation, thereby supporting faster tissue regeneration and improved wound closure. However, some limiting factors, such as poor bioavailability, low aqueous solubility, and rapid metabolism, have hindered the therapeutic efficacy of CUR.
OBJECTIVE(S): This study aimed to evaluate the wound healing potential of a newly developed nanoformulation, curcumin-loaded Pluronic (PF), NanoCUR, by assessing its antioxidant capacity, cytotoxicity, and effects on inflammatory cytokines in vitro.
MATERIALS & METHODS: NanoCUR was synthesised using a thin-film hydration method and characterised for size, size distribution, zeta potential, morphology, drug loading, and loading efficiency. The antioxidant capacity of NanoCUR was assessed using the ferric-reducing antioxidant power (FRAP) assay, while its cytotoxicity was evaluated in 3T3-NIH murine fibroblast cells. The wound-healing property was determined through a migration assay, and its effect on tumour necrosis factor alpha (TNF-α) expression in lipopolysaccharide (LPS)-induced RAW 264.7 macrophage cells was analysed via polymerase chain reaction (PCR).
RESULTS: NanoCUR exhibited a drug loading of 18.89 ± 0.60 mg CUR/g, a loading efficiency of 96.39 ± 3.04%, a zeta potential of -2.11 mV, a particle size of 25.79 nm, and a size distribution of 0.236. Ultraviolet-Visible (UV-Vis) spectroscopy and Fourier Transform Infrared (FTIR) spectroscopy confirmed successful CUR encapsulation, enhancing its antioxidant activity significantly at 100 µM and 150 µM compared with CUR. Toxicity profiling showed significantly lower cytotoxicity for NanoCUR in 3T3 cells, with median lethal concentration (LC50) values of 91.87 ± 0.02 µM (24h), 36.57 ± 0.05 µM (48h), and 20.63 ± 0.06 µM (72h) compared with CUR. Migration assays at 5 µM and 10 µM revealed enhanced wound closure over 72 hours. NanoCUR significantly suppressed TNF-α expression (p < 0.0001) in LPS-induced RAW 264.7 macrophage cells at 5 µM and 10 µM with increased cellular uptake.
CONCLUSION: These findings highlight the potential of NanoCUR for wound healing with improved toxicity, as well as antioxidant and anti-inflammatory properties. Further studies, particularly in vivo, are warranted to validate these findings.
KEYWORDS: Curcumin, NanoCUR, Pluronic, Wound Healing, Inflammation


